vs

Side-by-side financial comparison of Avidbank Holdings, Inc. (AVBH) and Paysign, Inc. (PAYS). Click either name above to swap in a different company.

Avidbank Holdings, Inc. is the larger business by last-quarter revenue ($28.0M vs $22.8M, roughly 1.2× Paysign, Inc.). Avidbank Holdings, Inc. runs the higher net margin — 32.3% vs 6.0%, a 26.3% gap on every dollar of revenue.

Avidbank Holdings, Inc. is a U.S.-based financial holding company operating through its subsidiary AvidBank. It offers commercial banking products and services primarily to small and medium-sized enterprises, business owners, and high-net-worth individuals across California, including commercial loans, deposit accounts, cash management, and customized financing solutions for sectors like manufacturing, technology, real estate and professional services.

Paysign, Inc. is a specialized payment solutions provider that designs and delivers customized prepaid card programs, end-to-end payment processing services, and digital disbursement tools. Its core served segments include healthcare, corporate incentives, and general consumer markets, with primary operations and client bases across North America.

AVBH vs PAYS — Head-to-Head

Bigger by revenue
AVBH
AVBH
1.2× larger
AVBH
$28.0M
$22.8M
PAYS
Higher net margin
AVBH
AVBH
26.3% more per $
AVBH
32.3%
6.0%
PAYS

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AVBH
AVBH
PAYS
PAYS
Revenue
$28.0M
$22.8M
Net Profit
$9.0M
$1.4M
Gross Margin
57.7%
Operating Margin
8.1%
Net Margin
32.3%
6.0%
Revenue YoY
45.8%
Net Profit YoY
65.9%
-0.7%
EPS (diluted)
$0.84
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AVBH
AVBH
PAYS
PAYS
Q1 26
$28.0M
Q4 25
$26.8M
$22.8M
Q3 25
$48.0K
$21.6M
Q2 25
$21.8M
$19.1M
Q1 25
$18.6M
Q4 24
$15.6M
Q3 24
$15.3M
Q2 24
$14.3M
Net Profit
AVBH
AVBH
PAYS
PAYS
Q1 26
$9.0M
Q4 25
$6.9M
$1.4M
Q3 25
$-37.7M
$2.2M
Q2 25
$5.8M
$1.4M
Q1 25
$2.6M
Q4 24
$1.4M
Q3 24
$1.4M
Q2 24
$697.1K
Gross Margin
AVBH
AVBH
PAYS
PAYS
Q1 26
Q4 25
57.7%
Q3 25
56.3%
Q2 25
61.6%
Q1 25
62.9%
Q4 24
58.9%
Q3 24
55.5%
Q2 24
52.9%
Operating Margin
AVBH
AVBH
PAYS
PAYS
Q1 26
Q4 25
8.1%
Q3 25
-110491.7%
7.3%
Q2 25
38.0%
7.5%
Q1 25
13.4%
Q4 24
3.0%
Q3 24
4.5%
Q2 24
0.9%
Net Margin
AVBH
AVBH
PAYS
PAYS
Q1 26
32.3%
Q4 25
25.9%
6.0%
Q3 25
-78614.6%
10.3%
Q2 25
26.6%
7.3%
Q1 25
13.9%
Q4 24
8.8%
Q3 24
9.4%
Q2 24
4.9%
EPS (diluted)
AVBH
AVBH
PAYS
PAYS
Q1 26
$0.84
Q4 25
$0.65
$0.02
Q3 25
$-4.12
$0.04
Q2 25
$0.75
$0.02
Q1 25
$0.05
Q4 24
$0.02
Q3 24
$0.03
Q2 24
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AVBH
AVBH
PAYS
PAYS
Cash + ST InvestmentsLiquidity on hand
Total DebtLower is stronger
$55.0M
Stockholders' EquityBook value
$287.2M
$48.5M
Total Assets
$2.5B
$276.3M
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Total Debt
AVBH
AVBH
PAYS
PAYS
Q1 26
$55.0M
Q4 25
$60.0M
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
AVBH
AVBH
PAYS
PAYS
Q1 26
$287.2M
Q4 25
$278.4M
$48.5M
Q3 25
$273.1M
$45.8M
Q2 25
$204.4M
$42.2M
Q1 25
$39.3M
Q4 24
$30.4M
Q3 24
$28.5M
Q2 24
$26.9M
Total Assets
AVBH
AVBH
PAYS
PAYS
Q1 26
$2.5B
Q4 25
$2.5B
$276.3M
Q3 25
$2.4B
$209.5M
Q2 25
$2.4B
$193.9M
Q1 25
$205.1M
Q4 24
$179.0M
Q3 24
$167.0M
Q2 24
$182.3M
Debt / Equity
AVBH
AVBH
PAYS
PAYS
Q1 26
0.19×
Q4 25
0.22×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AVBH
AVBH
PAYS
PAYS
Operating Cash FlowLast quarter
$48.1M
Free Cash FlowOCF − Capex
$47.5M
FCF MarginFCF / Revenue
208.7%
Capex IntensityCapex / Revenue
2.6%
Cash ConversionOCF / Net Profit
35.29×
TTM Free Cash FlowTrailing 4 quarters
$51.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AVBH
AVBH
PAYS
PAYS
Q1 26
Q4 25
$48.1M
Q3 25
$12.4M
$6.8M
Q2 25
$10.7M
$3.6M
Q1 25
$-6.0M
Q4 24
$14.3M
Q3 24
$-20.2M
Q2 24
$20.6M
Free Cash Flow
AVBH
AVBH
PAYS
PAYS
Q1 26
Q4 25
$47.5M
Q3 25
$12.4M
$6.3M
Q2 25
$10.6M
$3.6M
Q1 25
$-6.1M
Q4 24
$14.2M
Q3 24
$-20.3M
Q2 24
$20.4M
FCF Margin
AVBH
AVBH
PAYS
PAYS
Q1 26
Q4 25
208.7%
Q3 25
25783.3%
29.2%
Q2 25
48.6%
18.6%
Q1 25
-32.9%
Q4 24
91.0%
Q3 24
-133.0%
Q2 24
142.4%
Capex Intensity
AVBH
AVBH
PAYS
PAYS
Q1 26
Q4 25
2.6%
Q3 25
72.9%
2.1%
Q2 25
0.3%
0.5%
Q1 25
0.4%
Q4 24
0.7%
Q3 24
0.8%
Q2 24
1.0%
Cash Conversion
AVBH
AVBH
PAYS
PAYS
Q1 26
Q4 25
35.29×
Q3 25
3.05×
Q2 25
1.84×
2.62×
Q1 25
-2.33×
Q4 24
10.43×
Q3 24
-14.03×
Q2 24
29.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AVBH
AVBH

Net Interest Income$26.5M95%
Noninterest Income$1.5M5%

PAYS
PAYS

Plasma Industry$12.6M55%
Pharma Industry$9.6M42%
Other$558.4K2%

Related Comparisons